title: Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: Early detection strategies.
authors.affiliation: Medical Practices Evaluation Center, Massachusetts General Hospital, Boston 02114, USA.
authors.forename: C M
authors.initials: CM
authors.lastname: Coley
authors.forename: M J
authors.initials: MJ
authors.lastname: Barry
authors.forename: C
authors.initials: C
authors.lastname: Fleming
authors.forename: J H
authors.initials: JH
authors.lastname: Wasson
authors.forename: M C
authors.initials: MC
authors.lastname: Fahs
authors.forename: J E
authors.initials: JE
authors.lastname: Oesterling
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D001707:Biopsy, Needle; D006801:Humans; D016013:Likelihood Functions; D008297:Male; D006278:Medicare / Q000191:economics*; D008875:Middle Aged; D010808:Physical Examination; D011467:Prostate / Q000000981:diagnostic imaging / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000032:analysis*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000191:economics / Q000453:epidemiology; D012015:Reference Standards; D012051:Reimbursement Mechanisms; D014463:Ultrasonography; D014481:United States
chemical_list: D017430:Prostate-Specific Antigen